JP2003202336A - Method for dyeing corneocyte and method for preparing corneocyte specimen - Google Patents

Method for dyeing corneocyte and method for preparing corneocyte specimen

Info

Publication number
JP2003202336A
JP2003202336A JP2002060346A JP2002060346A JP2003202336A JP 2003202336 A JP2003202336 A JP 2003202336A JP 2002060346 A JP2002060346 A JP 2002060346A JP 2002060346 A JP2002060346 A JP 2002060346A JP 2003202336 A JP2003202336 A JP 2003202336A
Authority
JP
Japan
Prior art keywords
keratinocytes
specimen
dyeing
staining
keratinocyte
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002060346A
Other languages
Japanese (ja)
Other versions
JP3618093B2 (en
Inventor
Nobuo Kashibuchi
暢夫 橿淵
Jiro Yabusaki
次郎 藪崎
Toshikazu Yagi
寿和 八木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pola Chemical Industries Inc
Original Assignee
Pola Chemical Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pola Chemical Industries Inc filed Critical Pola Chemical Industries Inc
Priority to JP2002060346A priority Critical patent/JP3618093B2/en
Priority to KR10-2002-0017652A priority patent/KR100458148B1/en
Priority to TW091107588A priority patent/TW531403B/en
Priority to US10/123,440 priority patent/US20030087333A1/en
Priority to EP02252807A priority patent/EP1306658A3/en
Priority to EP07006149A priority patent/EP1845359A3/en
Publication of JP2003202336A publication Critical patent/JP2003202336A/en
Priority to US10/847,761 priority patent/US7425427B2/en
Priority to US10/848,233 priority patent/US7421105B2/en
Priority to KR10-2004-0035831A priority patent/KR100448303B1/en
Application granted granted Critical
Publication of JP3618093B2 publication Critical patent/JP3618093B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

<P>PROBLEM TO BE SOLVED: To provide a method for dyeing corneocytes and a specimen preparing method capable of clearly dyeing the corneocytes in a short time and speedily grasping information useful for counseling. <P>SOLUTION: In the method for preparing the specimen obtained by dyeing a sample containing the corneocytes obtained by stripping skin by an adhesive body, the specimen dyed by a dyeing agent dissolved in a dyeing agent solution containing an organic solvent miscible with water is sealed by fat and oil constituents and/or oil and fat compositions which are liquids at 25°C and one atmospheric pressure. <P>COPYRIGHT: (C)2003,JPO

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は、肌の状態の鑑別や
化粧料の適切な選択に有用な情報を与える、角質細胞の
染色方法及び角質細胞標本の作成方法に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for staining keratinocytes and a method for preparing a keratinocyte sample, which provides information useful for differentiation of skin condition and proper selection of cosmetics.

【0002】[0002]

【従来の技術】肌の状態は、季節、体調などの変動要因
や、化粧料の塗布などのお手入れなどによって時々刻々
変化するものであり、変化にあわせて適切な化粧料を選
択することが、老化を防止したり、肌の性状を美しく保
ったりする上で重要な因子となってくる。この為、肌の
性状や状態を客観的且つ科学的に鑑別する方法が考案さ
れている。この様な方法としては、例えば、顔などの肌
より角質細胞を粘着テープや粘着ディスクで採取し、こ
れを染色し、角質細胞の配列の規則性、角質細胞の形、
角質細胞の大きさ、剥がれ方、角質細胞に於ける核の有
無等を指標に肌の状態などを鑑別することが例示でき
る。この様な鑑別に於いては、バックと細胞質とのコン
トラストが明確に出来、これにより個々の細胞の形状が
確認できると同時に核の有無の存在も確認できる染色法
が好ましいため、ゲンチアナバイオレットとブリリアン
トグリーンとによって染色する方法がとられている。し
かしながら、この方法に於いては、染色には時間がかか
るため、カウンセリングなどの場において即断するため
の情報源とはならず、角質細胞の形状を指標とする肌の
鑑別で化粧料などを選択する場合には、肌分析から化粧
料サンプルの提示まで数日を要し、タイムラグが生じて
しまう欠点があった。通常、この様な場合には染色剤の
濃度を上げることが検討されるが、ゲンチアナバイオレ
ットもブリリアントグリーンも水に対する溶解限度まで
濃度を上げても(ゲンチアナバイオレット1%、ブリリ
アントグリーン0.5%)、その染色には10分以上か
かってしまい、染色に要する時間の問題は依然残った。
染色に於いては通常有機溶剤の使用は、染色特異性を損
なったり、細胞の変質、変性を起こしたりするためにタ
ブーとされており、この様な角質細胞の染色には用いら
れていない。従って、皮膚を粘着体でストリップして得
た角質細胞を含む試料の染色法であって、前記染色工程
に於ける染色剤溶液が水と混和可能な有機溶剤を含有す
ることを特徴とする、角質細胞の染色法は全く知られて
いない。
2. Description of the Related Art The condition of the skin changes from moment to moment depending on factors such as the season and physical condition, and the maintenance of applying cosmetics. Therefore, it is possible to select an appropriate cosmetic according to the changes. , It is an important factor in preventing aging and keeping the skin's properties beautiful. For this reason, a method for objectively and scientifically distinguishing the nature and condition of the skin has been devised. As such a method, for example, keratinocytes are collected from the skin such as a face with an adhesive tape or an adhesive disc, stained, and the regularity of the arrangement of keratinocytes, the shape of keratinocytes,
For example, the skin condition and the like can be differentiated by using the size and the exfoliation of keratinocytes, the presence or absence of nuclei in keratinocytes and the like as indices. In such discrimination, a staining method is preferred in which the contrast between the bag and the cytoplasm can be clearly defined, and thus the shape of individual cells can be confirmed, and at the same time the presence or absence of nuclei can be confirmed.Therefore, gentian violet and brilliant The method of dyeing with green is taken. However, in this method, since dyeing takes time, it does not serve as an information source for immediate cuts in counseling and other situations, and cosmetics etc. are selected by skin differentiation using the shape of keratinocytes as an index. In this case, it takes several days from the skin analysis to the presentation of the cosmetic sample, which causes a time lag. Usually, in such a case, it is considered to increase the concentration of the dyeing agent, but even if the concentration of both gentian violet and brilliant green is increased to the solubility limit in water (gentian violet 1%, brilliant green 0.5%). However, the dyeing took 10 minutes or more, and the problem of the time required for dyeing remained.
In the staining, the use of an organic solvent is usually taboo because it impairs the staining specificity and causes the alteration and degeneration of cells, and is not used for staining such keratinocytes. Therefore, a method for dyeing a sample containing keratinocytes obtained by stripping skin with an adhesive, wherein the dyeing solution in the dyeing step contains an organic solvent miscible with water, No method for staining keratinocytes is known.

【0003】更に、通常染色された角質細胞サンプルは
標本全体の屈折率を同じに調整するため、封入の操作を
行うが、かかる封入剤としてはバルサムや紫外線硬化樹
脂が通常用いられている。しかしながら、これらの封入
剤は往々にして染色剤のにじみを誘発するため、細胞の
面積などを二値化によって自動計測する場合には誤差を
大きくしてしまうため好ましくない。加えて、粘着テー
プを角質細胞の採取に用いた場合には、この様な封入に
使用される有機溶剤によってテープや粘着剤が溶解して
しまうこともあり使用は不可能である。前記のようにカ
ウンターカウンセリングなどによって迅速な角質細胞の
分析を行う場合には、面積の測定の二値化による自動化
は避けられず、このにじみの解決は特に重要な事項であ
り、この解決は強く望まれていた。この様な封入に1気
圧、25℃で液体の油脂成分及び/又は油脂組成物が用
いられたことはない。これは、液体の封入剤は1ヶ月以
上の保存が困難であることと、この様な素材が封入剤と
して今まで使用されたことが皆無であったためである。
従って、この様な封入剤を用いることにより、染色剤の
にじみが殆どない、二値化による角質細胞面積の自動測
定が可能な角質細胞標本が作成できることは全く知られ
ていなかった。
Further, normally stained keratinocyte samples are subjected to an encapsulation operation in order to adjust the refractive index of the entire specimen to be the same, and as such an encapsulating agent, balsam or an ultraviolet curable resin is usually used. However, these encapsulating agents often induce bleeding of the staining agent, which is not preferable because it causes a large error when automatically measuring the cell area and the like by binarization. In addition, when the adhesive tape is used for collecting keratinocytes, the organic solvent used for such encapsulation may dissolve the tape and the adhesive, and therefore cannot be used. When performing rapid keratinocyte analysis by countercounseling as described above, automation by binarization of area measurement is unavoidable, and the solution of this bleeding is a particularly important matter, and this solution is strongly recommended. Was wanted. The oil / fat component and / or oil / fat composition which is liquid at 1 atm and 25 ° C. has never been used for such encapsulation. This is because the liquid encapsulant is difficult to store for more than one month, and no such material has ever been used as an encapsulant.
Therefore, it has not been known at all that the use of such an encapsulating agent can produce a keratinocyte preparation capable of automatic measurement of the keratinocyte area by binarization with almost no bleeding of the staining agent.

【0004】[0004]

【発明が解決しようとする課題】本発明は、短時間で角
質細胞が明瞭に染色でき、カウンセリングに有用な情報
を迅速につかめる、角質細胞の染色方法及び角質細胞標
本の作成方法を提供することを課題とする。
DISCLOSURE OF THE INVENTION The present invention provides a method for staining a keratinocyte and a method for preparing a keratinocyte specimen, which allows a keratinocyte to be clearly stained in a short time and information useful for counseling can be quickly grasped. Is an issue.

【0005】[0005]

【課題を解決するための手段】本発明者らは、この様な
状況に鑑みて、短時間で角質細胞が明瞭に染色でき、カ
ウンセリングに有用な情報を迅速につかめる、角質細胞
の染色方法及び角質細胞標本の作成方法を求めて、鋭意
研究努力を重ねた結果、皮膚を粘着体でストリップして
得た角質細胞を含む試料の染色方法であって、前記染色
工程に於ける染色剤溶液が水と混和可能な有機溶剤を含
有することを特徴とする、角質細胞の染色法で染色する
ことにより短時間で鮮明な染色が可能となり、更に前記
染色した標本を1気圧、25℃で液体の油脂成分及び/
又は油脂組成物で封入することにより、染色剤のにじみ
なく封入することが可能となり、従って、標本からの角
質細胞について、二値化、角質細胞面積の自動測定が可
能となることを見出し発明を完成させるに至った。即
ち、本発明は、以下に示す技術に関するものである。 (1)皮膚を粘着体でストリップして得た角質細胞を含
む試料の染色方法であって、染色工程に於ける染色剤溶
液が水と混和可能な有機溶剤を含有することを特徴とす
る、角質細胞の染色方法。 (2)染色剤がゲンチアナバイオレットとブリリアント
グリーンを含有するものであることを特徴とする、
(1)に記載の角質細胞の染色方法。 (3)水と混和可能な有機溶媒が、エタノールであるこ
とを特徴とする、(1)又は(2)に記載の角質細胞の
染色方法。 (4)粘着体が粘着テープであることを特徴とする、
(1)〜(3)何れか1項に記載の角質細胞の染色方
法。 (5)皮膚を粘着体でストリップして得た角質細胞を含
む試料を染色した標本の作成方法であって、染色された
標本を1気圧、25℃で液体の油脂成分及び/又は油脂
組成物で封入することを特徴とする、角質細胞標本の作
成方法。 (6)封入に用いる1気圧25℃で液体の油脂成分及び
/又は油脂組成物がシリコーン油、脂肪酸トリグリセラ
イド、高級アルコールと脂肪酸のエステル及び炭化水素
から選択される1種乃至は2種以上であることを特徴と
する、(5)に記載の角質細胞標本の作成方法。 (7)角質細胞を含む試料の染色が(1)〜(4)何れ
か1項に記載の角質細胞の染色方法によって染色された
ものであることを特徴とする、(5)又は(6)に記載
の角質細胞標本の作成方法。 (8)角質細胞の面積測定、有核細胞の存在の有無、有
核細胞の出現頻度、角質細胞の配列の規則性、角質細胞
の形、及び角質細胞の剥離状況から選択される1種乃至
は2種以上の測定又は判別用であることを特徴とする
(5)〜(7)何れか1項に記載の角質細胞標本の作成
方法。以下、本発明について、実施の形態を中心に更に
詳細に説明を加える。
In view of such a situation, the inventors of the present invention have a method for staining keratinocytes, in which keratinocytes can be clearly stained in a short time, and information useful for counseling can be quickly grasped. As a result of intensive research efforts to find a method for preparing a keratinocyte specimen, a method for staining a sample containing keratinocytes obtained by stripping skin with an adhesive body, wherein the stain solution in the staining step is By virtue of containing an organic solvent miscible with water, it becomes possible to perform clear staining in a short time by staining with a keratinocyte staining method. Furthermore, the stained specimen is liquid at 1 atm and 25 ° C. Oil and fat component and /
Alternatively, by encapsulating with an oil / fat composition, it is possible to enclose the dye without bleeding, and therefore, for keratinocytes from a specimen, it is possible to binarize and automatically measure the area of keratinocytes. It came to completion. That is, the present invention relates to the techniques described below. (1) A method for dyeing a sample containing keratinocytes obtained by stripping skin with an adhesive body, wherein the dyeing solution in the dyeing step contains an organic solvent miscible with water, Method for staining keratinocytes. (2) The stain is characterized by containing gentian violet and brilliant green.
The method for staining keratinocytes according to (1). (3) The method for staining keratinocytes according to (1) or (2), wherein the organic solvent miscible with water is ethanol. (4) The adhesive body is an adhesive tape,
(1) to (3) The method for staining keratinocytes according to any one of items. (5) A method for producing a specimen in which a sample containing keratinocytes obtained by stripping the skin with an adhesive material is stained, wherein the stained specimen is a liquid oil component and / or oil composition at 1 atm and 25 ° C. A method for preparing a keratinocyte specimen, which is characterized in that (6) The oil / fat component and / or oil / fat composition that is liquid at 1 atmosphere and 25 ° C. for encapsulation is one or more kinds selected from silicone oil, fatty acid triglyceride, ester of higher alcohol and fatty acid, and hydrocarbon. The method for producing a keratinocyte specimen according to (5), which is characterized in that (7) The sample containing keratinocytes is stained by the method for staining keratinocytes according to any one of (1) to (4), (5) or (6) The method for preparing a keratinocyte preparation according to. (8) One or more types selected from area measurement of keratinocytes, presence / absence of nucleated cells, appearance frequency of nucleated cells, regularity of keratinocyte array, keratinocyte shape, and keratinocyte detachment state Is for measuring or discriminating two or more kinds, (5) to (7) The method for preparing a keratinocyte specimen according to any one of (1) to (7). Hereinafter, the present invention will be described in more detail with a focus on the embodiments.

【0006】[0006]

【発明の実施の形態】(1)本発明の角質細胞の染色方
法 本発明の角質細胞の染色方法は、皮膚を粘着体でストリ
ップして得た角質細胞を含む試料の染色方法であって、
前記染色工程に於ける染色剤溶液が水と混和可能な有機
溶剤を含有することを特徴とする。即ち、本発明は、水
と混和可能な有機溶剤で染色剤を溶解したもので、皮膚
を粘着体でストリップして得た角質細胞を含む試料を染
色することを特徴とする。ここで、皮膚をストリップす
る粘着体としては、例えばセロハンテープなどの粘着透
明テープやポリエチレンテレフタレート板に粘着剤を塗
工した粘着ディスクなどが好ましく例示できる。この
内、好ましいものは市販品が存在し、入手が極めて容易
である、粘着テープである。かかる粘着体で肌をストリ
ップして得た試料はそのまま染色させることもできる
し、再度粘着体に接触させて転写させて使用することも
できる。好ましい方法はそのまま使用する方法であり、
これは手間が減らせるからである。本発明の染色法によ
れば、粘着剤やテープやディスクなどの粘着体の支持体
部分にも影響を与えることがないため、採取した形態で
そのまま染色することができる。本発明の染色法では通
常使用されている染色剤であれば特段の限定なく使用で
き、例えば、エオシン、ヘマトキシリン、ゲンチアナバ
イオレット、ブリリアントグリーン、マラカイトグリー
ンなどが好ましく例示でき、これらは唯一種でも二種以
上を組み合わせても使用できる。これらの内ではゲンチ
アナバイオレットとブリリアントグリーンを組み合わせ
て用いるのが特に好ましい。これは、ゲンチアナバイオ
レットによってバックグランドに対してコントラスト良
く細胞質を染色できるため、角質細胞の形状を明確にす
ることが可能であり、かかる細胞質をバックグランドと
して、ブリリアントグリーンによって明瞭に核が染色で
きるからである。かかる染色剤を水と可溶な有機溶剤を
含む液体媒体に溶解させ染色することが本発明の染色法
の特徴である。染色剤の好ましい含有量は、2〜7重量
%であり、ゲンチアナバイオレットとブリリアントグリ
ーンの組み合わせであれば、ゲンチアナバイオレットが
1.5〜5重量%であり、更に好ましくは2〜4重量%
であり、ブリリアントグリーンが0.7〜2重量%であ
り、更に好ましくは0.8〜1.5重量%である。又、
水と可溶な有機溶剤としては、例えば、メタノール、エ
タノール、イソプロパノール、1,3−ブタンジオール
等のアルコール類、アセトン、メチルエチルケトンなど
のケトン類、アセトニトリルなどのニトリル類、テトラ
ヒドロフランの様なエーテル類などが好ましく例示でき
る。これらの中ではアルコール類が好ましく、中でもエ
タノールが特に好ましい。かかる水に可溶な有機溶剤の
液体媒体に於ける好ましい含有量は、3〜55重量%で
あり、更に好ましくは5〜50重量%である。これは有
機溶剤が多すぎても時間は短縮しないし、却って粘着剤
や粘着体の支持体を損なう場合があり、少なすぎると染
色鮮明化効果が得られない場合があるからである。この
様な本発明の条件下に於いては、染色に要する時間は1
〜5分程度であり、従来の方法(ゲンチアナバイオレッ
ト0.5〜1重量%とブリリアントグリーン0.2〜
0.5重量%)の10〜30分に比して格段の時間短縮
を見ている上に、コントラストの明瞭化も著しい。又、
この様な染色は室温でも行うことができる。
BEST MODE FOR CARRYING OUT THE INVENTION (1) Method for Staining Corneal Cells of the Present Invention The method for staining keratinocytes of the present invention is a method for staining a sample containing keratinocytes obtained by stripping skin with an adhesive.
The dyeing solution in the dyeing step contains an organic solvent miscible with water. That is, the present invention is characterized in that a dye is dissolved in an organic solvent miscible with water, and a sample containing keratinocytes obtained by stripping the skin with an adhesive is dyed. Here, as the adhesive body for stripping the skin, for example, an adhesive transparent tape such as cellophane tape or an adhesive disk obtained by coating an adhesive on a polyethylene terephthalate plate can be preferably exemplified. Of these, preferred are adhesive tapes that are commercially available and are extremely easy to obtain. The sample obtained by stripping the skin with such an adhesive can be dyed as it is, or it can be used again by contacting it with the adhesive and transferring it. The preferred method is to use it as is,
This is because the labor can be reduced. According to the dyeing method of the present invention, since it does not affect the pressure-sensitive adhesive or the support portion of the pressure-sensitive adhesive body such as a tape or disk, it can be dyed as it is in the collected form. In the dyeing method of the present invention, any commonly used dyeing agent can be used without particular limitation, and examples thereof include eosin, hematoxylin, gentian violet, brilliant green, and malachite green. A combination of the above can also be used. Of these, it is particularly preferable to use gentian violet and brilliant green in combination. This is because gentian violet can stain the cytoplasm with a good contrast to the background, so that it is possible to clarify the shape of keratinocytes, and with this cytoplasm as the background, the nucleus can be clearly stained with brilliant green. Is. The dyeing method of the present invention is characterized by dissolving such a dyeing agent in a liquid medium containing water and an organic solvent which is soluble in the dyeing agent. The preferred content of the coloring agent is 2 to 7% by weight, and if the combination of gentian violet and brilliant green is 1.5 to 5% by weight of gentian violet, more preferably 2 to 4% by weight.
And the brilliant green content is 0.7 to 2% by weight, and more preferably 0.8 to 1.5% by weight. or,
Examples of the water-soluble organic solvent include alcohols such as methanol, ethanol, isopropanol, and 1,3-butanediol, ketones such as acetone and methyl ethyl ketone, nitriles such as acetonitrile, ethers such as tetrahydrofuran, and the like. Can be preferably exemplified. Of these, alcohols are preferable, and ethanol is particularly preferable. The content of the water-soluble organic solvent in the liquid medium is preferably 3 to 55% by weight, more preferably 5 to 50% by weight. This is because if the amount of the organic solvent is too large, the time is not shortened, and on the contrary, the pressure-sensitive adhesive or the support of the pressure-sensitive adhesive may be damaged, and if it is too small, the dye-sharpening effect may not be obtained. Under such conditions of the present invention, the time required for dyeing is 1
~ 5 minutes, the conventional method (gentian violet 0.5-1% by weight and brilliant green 0.2-
0.5% by weight), the time is remarkably shortened compared to 10 to 30 minutes, and the contrast is also made clear. or,
Such dyeing can be performed at room temperature.

【0007】(2)本発明の角質細胞標本の作成方法 本発明の角質細胞標本の作成方法は、皮膚を粘着体でス
トリップして得た角質細胞を含む試料の染色した標本の
作成方法であって、前記染色した標本を1気圧、25℃
で液体の油脂成分及び/又は油脂組成物で封入すること
を含むことを特徴とする。ここで、皮膚を粘着体でスト
リップして得た角質細胞を含む試料の染色したサンプル
としては、通常この様な工程で作成されているものであ
れば何れも適用可能であるが、特に好ましいものは、前
記(1)の本発明の角質細胞の染色方法によって染色さ
れたサンプルである。本発明の角質細胞標本作成法で使
用する、1気圧、25℃で液体の油脂成分及び/又は油
脂組成物としては、通常化粧料や医薬で使用される油脂
分或いはそれらを組み合わせた組成物であって、1気圧
25℃で液状のものであれば特段の限定なく使用するこ
とができる。この様なものの好ましい組み合わせとして
は、1気圧、25℃で液体の、シリコーン油、脂肪酸ト
リグリセライド、高級アルコールと脂肪酸のエステル及
び炭化水素から選択される1種乃至は2種以上が好まし
く例示できる。通常液体成分による封入は通常1ヶ月以
上の安定性が得られないが、本発明の目的とする、カウ
ンターでのカウンセリングのような即時的な使用では何
ら問題がない。前記油剤に於いては染色剤のにじみは認
められず、得られた標本の顕微鏡像を画像として取り込
み、染色しているかいないかの2つの値に分けて(二値
化処理)角質細胞の形状を正確に浮かび上がらせること
が出来、これによって角質細胞面積を正確に自動計測す
ることができる。これ以外に本発明の標本作成法によっ
て製造された標本から得られる情報としては、有核細胞
の存在の有無、有核細胞の出現頻度及び角質細胞の剥離
状況、角質細胞の配列の規則性、角質細胞の形等が挙げ
られ、本発明の標本はこれらの数値の測定又は判別に用
いられることが好ましい。即ち、本発明の方法によって
作成された角質細胞標本は、角質細胞の面積測定、有核
細胞の存在の有無、有核細胞の出現頻度、角質細胞の配
列の規則性、角質細胞の形、及び角質細胞の剥離状況か
ら選択される1種乃至は2種以上の測定又は判別用に用
いられることが好ましい。
(2) Method of preparing keratinocyte specimen of the present invention The method of preparing keratinocyte specimen of the present invention is a method of preparing a stained specimen containing keratinocytes obtained by stripping skin with an adhesive. The stained specimen at 1 atm and 25 ° C.
And encapsulating with a liquid oil component and / or oil composition. Here, as the stained sample of the sample containing keratinocytes obtained by stripping the skin with an adhesive body, any sample that is usually prepared in such a step can be applied, but particularly preferable one Is a sample stained by the method for staining keratinocytes of the present invention described in (1) above. The oil and fat component and / or oil and fat composition that is liquid at 1 atm and 25 ° C. and is used in the method for preparing a keratinocyte specimen of the present invention is an oil or fat component usually used in cosmetics and medicines, or a composition combining them. Therefore, as long as it is liquid at 1 atm 25 ° C., it can be used without particular limitation. As a preferable combination of such substances, one or more kinds selected from silicone oil, fatty acid triglyceride, ester of higher alcohol and fatty acid, and hydrocarbon which are liquid at 1 atm and 25 ° C. can be preferably exemplified. Usually, encapsulation with a liquid component does not usually give stability for one month or more, but there is no problem in the immediate use such as counseling in a counter, which is the object of the present invention. No bleeding of the staining agent was observed in the oil agent, and the microscopic image of the obtained specimen was captured as an image and divided into two values, whether stained or not (binarization treatment), the shape of keratinocytes. Can be accurately displayed, and thus the keratinocyte area can be accurately and automatically measured. In addition to this, the information obtained from the sample produced by the method for preparing a sample of the present invention includes the presence or absence of nucleated cells, the appearance frequency of nucleated cells and the state of keratinocyte detachment, the regularity of the arrangement of keratinocytes, Examples thereof include the shape of keratinocytes, and the sample of the present invention is preferably used for measuring or discriminating these numerical values. That is, the keratinocyte sample prepared by the method of the present invention is an area measurement of keratinocytes, the presence or absence of nucleated cells, the frequency of appearance of nucleated cells, the regularity of the arrangement of keratinocytes, the shape of keratinocytes, and It is preferable to use one or more kinds selected from the exfoliation status of keratinocytes for measurement or discrimination.

【0008】[0008]

【実施例】以下に、実施例を挙げて本発明について更に
詳細に説明を加えるが、本発明がこれら実施例にのみ限
定されないことは言うまでもない。
The present invention will be described in more detail below with reference to examples, but it goes without saying that the present invention is not limited to these examples.

【0009】<実施例1>同一パネラーより角質細胞を
粘着テープストリッピングにより3種採取し、2種は本
発明の染色法によって染色した。即ち、ゲンチアナバイ
オレット3重量%とブリリアントグリーン1重量%を2
0%エタノール水溶液に溶解させた染色液に2分間浸漬
し、充分に水洗した。1方は紫外線硬化樹脂に封入し、
紫外線を照射し硬化させた(比較例1)。もう1方は本
発明の角質細胞標本の作成方法に従って、ジメチコン
(シリコーン)に封入した(実施例1)。のこる1つは
ゲンチアナバイオレット1重量%とブリリアントグリー
ン0.5重量%を水に溶かした染色液に10分間浸漬
し、充分に水洗した後ジメチコンに封入した(比較例
2)。これらの標本の顕微鏡写真を図1〜3に示す。図
1〜3に示すように、比較例1ではにじみが生じること
でコントラストが小さくなり、比較例2では角質細胞の
染色が薄くなってしまうのに対し、実施例1ではにじみ
がなく(比較例1に比べてコントラストが大きく)且つ良
好な染色状態が得られた。これより、本発明の方法によ
って作られた角質細胞標本の作成法は角質細胞が鮮明且
つ明瞭に識別できることが判る。
<Example 1> From the same panel, 3 types of keratinocytes were collected by adhesive tape stripping, and 2 types were stained by the staining method of the present invention. That is, 2% by weight of gentian violet 3% by weight and 1% by weight of brilliant green
It was dipped in a dyeing solution dissolved in a 0% ethanol aqueous solution for 2 minutes and thoroughly washed with water. One is encapsulated in UV curable resin,
It was irradiated with ultraviolet rays and cured (Comparative Example 1). The other was encapsulated in dimethicone (silicone) according to the method for preparing a keratinocyte preparation of the present invention (Example 1). One of the saws was immersed in a dyeing solution prepared by dissolving 1% by weight of gentian violet and 0.5% by weight of brilliant green in water for 10 minutes, thoroughly washed with water, and then enclosed in dimethicone (Comparative Example 2). Micrographs of these specimens are shown in FIGS. As shown in FIGS. 1 to 3, in Comparative Example 1, bleeding causes a decrease in contrast, and in Comparative Example 2, staining of keratinocytes becomes thin, whereas in Example 1, there is no bleeding (Comparative Example The contrast was larger than that of No. 1) and a good dyeing condition was obtained. From this, it can be seen that the method of preparing a keratinocyte specimen prepared by the method of the present invention can clearly and clearly identify keratinocytes.

【0010】<実施例2>実施例1で作られた実施例
1、比較例1、比較例2の標本を用いて角質細胞の平均
面積を算出した。又、実施例1についてはマニュアルで
二値化して平均面積(単位:μm2)を算出した。平均
を算出するのに用いた細胞数は20個であった。結果を
表1に示す。これより、本発明によれば自動面積算出を
行ってもマニュアルと同じ結果が得られていることがわ
かる。又、細胞の不明確な標本やにじみのある標本では
自動面積算出では実際の面積より大きい値が出ているこ
とが判る。
<Example 2> Using the samples of Example 1, Comparative Example 1 and Comparative Example 2 prepared in Example 1, the average area of keratinocytes was calculated. Further, in Example 1, the average area (unit: μm 2) was calculated by binarizing manually. The number of cells used to calculate the average was 20. The results are shown in Table 1. From this, it can be seen that according to the present invention, the same result as the manual is obtained even if the automatic area calculation is performed. In addition, it can be seen that in the case of unclear cell specimens or specimens with bleeding, a value larger than the actual area is obtained in the automatic area calculation.

【0011】[0011]

【表1】 [Table 1]

【0012】<実施例3>実施例1の測定法に準じて、
ゲンチアナバイオレットの濃度を変えて検討を行った。
ブリリアントグリーンは1重量%のままであった。封入
はジメチコンを用いた。染色の鮮明さを「○:鮮明に染
色されている」、「△:やや不明瞭」、「×:不明瞭」
の判定基準で評価した。結果を表2に示す。これよりゲ
ンチアナバイオレットの好ましい含有量は、1.5〜5
重量%が好ましく、2〜4重量%が更に好ましいことが
判る。
<Example 3> According to the measuring method of Example 1,
The study was conducted by changing the concentration of gentian violet.
Brilliant green remained at 1% by weight. Dimethicone was used for encapsulation. The sharpness of dyeing is "○: Vividly dyed", "△: Somewhat unclear", "X: Unclear"
It evaluated by the judgment standard of. The results are shown in Table 2. From this, the preferred content of gentian violet is 1.5 to 5
It can be seen that weight percent is preferred and 2-4 weight percent is even more preferred.

【0013】[0013]

【表2】 [Table 2]

【0014】<実施例3>実施例3と同様にブリリアン
トグリーンの濃度を変えて同様の検討を行った。サンプ
ルとしては有核細胞の観察される皮膚状態の悪い人の角
質細胞標本を用いた。核の染色具合の鮮明度を実施例3
と同じ基準で判定した。結果を表3に示す。これよりブ
リリアントグリーンの好ましい濃度は0.7〜2重量%
であり、更に好ましくは0.8〜1.5重量%であるこ
とが判る。
<Example 3> Similar to Example 3, the same examination was conducted by changing the concentration of brilliant green. As a sample, a keratinocyte specimen of a person with a poor skin condition in which nucleated cells were observed was used. The sharpness of the dyeing condition of the nucleus was determined in Example 3.
It judged by the same standard as. The results are shown in Table 3. Therefore, the preferred concentration of brilliant green is 0.7-2% by weight.
It is found that it is 0.8 to 1.5% by weight, and more preferably 0.8 to 1.5% by weight.

【0015】[0015]

【表3】 [Table 3]

【0016】<実施例4>実施例1と同様の手法でエタ
ノールの濃度を変えて検討を行った。同時に染色剤の沈
殿(不溶部分)の有無も確認した。染色の明瞭さは
「○:鮮明に染色されている」、「△:やや不明瞭」、
「×:不明瞭」の判定基準で評価した。また、沈殿の有
無は「ある」、「わずかながらある」、「ない」で判定
した。結果を表4に示す。これより水に可溶な有機溶剤
の液体媒体に於ける好ましい含有量は、3〜40重量%
であり、更に好ましくは5〜30重量%であることがわ
かる。
<Example 4> By the same method as in Example 1, the concentration of ethanol was changed and examined. At the same time, the presence or absence of precipitate (insoluble portion) of the stain was also confirmed. The clarity of staining is "○: Vividly stained", "△: Slightly unclear",
Evaluation was made according to the criteria of "x: unclear". In addition, the presence or absence of precipitation was judged by "yes", "slightly" and "no". The results are shown in Table 4. Therefore, the preferable content of the water-soluble organic solvent in the liquid medium is 3 to 40% by weight.
It is found that it is 5 to 30% by weight, and more preferably 5 to 30% by weight.

【0017】[0017]

【表4】 [Table 4]

【0018】<実施例5>実施例1と同様に有機溶媒を
20%メタノール溶液に変えて検討を行ったが実施例1
と同様に鮮明な染色の標本が得られた。
<Embodiment 5> As in Embodiment 1, the examination was conducted by changing the organic solvent to a 20% methanol solution.
A specimen with clear staining was obtained in the same manner as in.

【0019】<実施例6>実施例1と同様に有機溶媒を
10%アセトニトリル溶液に変えて検討を行ったが実施
例1と同様に鮮明な染色の標本が得られた。
<Example 6> As in Example 1, an examination was conducted by changing the organic solvent to a 10% acetonitrile solution, but a sharply stained sample was obtained as in Example 1.

【0020】<実施例7>実施例1と同様の手法で封入
剤のみを変えて検討を行った。できあがったサンプルの
にじみの無さを、「○:全くにじみがない」、「△:少
しにじむ」、「×:明瞭ににじむ」の基準で判定した。
結果を表5に示す。これより本発明の各層標本作製には
封入剤として1気圧、25℃で液体の油脂成分及び/又
は油脂組成物を用いることが好適であることが判る。
<Example 7> In the same manner as in Example 1, an examination was conducted by changing only the encapsulant. The non-bleeding of the finished sample was judged by the criteria of "○: no bleeding", "△: slightly bleeding", and "x: clear bleeding".
The results are shown in Table 5. From this, it is understood that it is preferable to use a fat and oil component and / or a fat and oil composition which is liquid at 1 atm and 25 ° C. as an encapsulating agent for the preparation of each layer sample of the present invention.

【0021】[0021]

【表5】 [Table 5]

【0022】[0022]

【発明の効果】本発明によれば、短時間で角質細胞が明
瞭に染色でき、カウンセリングに有用な情報を迅速につ
かめる、角質細胞の染色方法及び角質細胞標本の作成方
法を提供することができる。
EFFECTS OF THE INVENTION According to the present invention, it is possible to provide a method for staining a keratinocyte and a method for preparing a keratinocyte specimen, which allows the keratinocyte to be clearly stained in a short time, and information useful for counseling can be quickly grasped. .

【図面の簡単な説明】[Brief description of drawings]

【図1】 実施例1の本発明の作成方法による角質細胞
標本の顕微鏡写真である。(図面代用写真)
FIG. 1 is a micrograph of a keratinocyte specimen prepared by the production method of the present invention in Example 1. (Drawing substitute photograph)

【図2】 実施例1の比較例1の作成方法による角質細
胞標本の顕微鏡写真である。(図面代用写真)
FIG. 2 is a micrograph of a keratinocyte specimen prepared by the method of Comparative Example 1 of Example 1. (Drawing substitute photograph)

【図3】 実施例1の比較例2の作成方法による角質細
胞標本の顕微鏡写真である。(図面代用写真)
FIG. 3 is a micrograph of a keratinocyte specimen prepared by the preparation method of Comparative Example 2 of Example 1. (Drawing substitute photograph)

【手続補正書】[Procedure amendment]

【提出日】平成15年3月18日(2003.3.1
8)
[Submission date] March 18, 2003 (2003.3.1)
8)

【手続補正1】[Procedure Amendment 1]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】図面の簡単な説明[Name of item to be corrected] Brief description of the drawing

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【図面の簡単な説明】[Brief description of drawings]

【図1】 実施例1の比較例1の本発明の作成方法によ
る角質細胞標本の顕微鏡写真である。(図面代用写真)
FIG. 1 is a micrograph of a keratinocyte specimen prepared by the production method of the present invention of Comparative Example 1 of Example 1 . (Drawing substitute photograph)

【図2】 実施例1の本発明の作成方法による角質細胞
標本の顕微鏡写真である。(図面代用写真)
FIG. 2 is a micrograph of a keratinocyte specimen prepared by the production method of the present invention in Example 1. (Drawing substitute photograph)

【図3】 実施例1の比較例2の作成方法による角質細
胞標本の顕微鏡写真である。(図面代用写真)
FIG. 3 is a micrograph of a keratinocyte specimen prepared by the preparation method of Comparative Example 2 of Example 1. (Drawing substitute photograph)

───────────────────────────────────────────────────── フロントページの続き (72)発明者 八木 寿和 静岡県袋井市愛野1234番地 ポーラ化成工 業株式会社袋井工場内 Fターム(参考) 2G045 AA24 BA14 BB02 BB23 BB25 CB09 FA16 FA20 GB01 HA06 JA01 2G052 AA33 AD32 AD52 BA23 DA07 DA27 FA02 FA09 GA32 HA17 HA18 HB06 JA06 JA07 JA09 JA11 4H011 BC19 CA02 CB08 CD02 CD13 DH07    ─────────────────────────────────────────────────── ─── Continued front page    (72) Inventor Toshikazu Yagi             1234 Aino, Fukuroi City, Shizuoka Prefecture             Fukuroi factory F term (reference) 2G045 AA24 BA14 BB02 BB23 BB25                       CB09 FA16 FA20 GB01 HA06                       JA01                 2G052 AA33 AD32 AD52 BA23 DA07                       DA27 FA02 FA09 GA32 HA17                       HA18 HB06 JA06 JA07 JA09                       JA11                 4H011 BC19 CA02 CB08 CD02 CD13                       DH07

Claims (8)

【特許請求の範囲】[Claims] 【請求項1】 皮膚を粘着体でストリップして得た角質
細胞を含む試料の染色方法であって、染色工程に於ける
染色剤溶液が水と混和可能な有機溶剤を含有することを
特徴とする、角質細胞の染色方法。
1. A method for dyeing a sample containing keratinocytes obtained by stripping skin with an adhesive, wherein the dyeing solution in the dyeing step contains an organic solvent miscible with water. A method for staining keratinocytes.
【請求項2】 染色剤がゲンチアナバイオレットとブリ
リアントグリーンを含有するものであることを特徴とす
る、請求項1に記載の角質細胞の染色方法。
2. The method for staining keratinocytes according to claim 1, wherein the staining agent contains gentian violet and brilliant green.
【請求項3】 水と混和可能な有機溶媒が、エタノール
であることを特徴とする、請求項1又は2に記載の角質
細胞の染色方法。
3. The method for staining keratinocytes according to claim 1, wherein the organic solvent miscible with water is ethanol.
【請求項4】 粘着体が粘着テープであることを特徴と
する、請求項1〜3何れか1項に記載の角質細胞の染色
方法。
4. The method for staining keratinocytes according to claim 1, wherein the adhesive body is an adhesive tape.
【請求項5】 皮膚を粘着体でストリップして得た角質
細胞を含む試料を染色した標本の作成方法であって、染
色された標本を1気圧、25℃で液体の油脂成分及び/
又は油脂組成物で封入することを特徴とする、角質細胞
標本の作成方法。
5. A method for preparing a specimen in which a sample containing keratinocytes obtained by stripping the skin with an adhesive material is stained, wherein the stained specimen is a liquid oil and fat component at 1 atm and 25 ° C.
Alternatively, a method for preparing a keratinocyte specimen, which comprises encapsulating with an oil composition.
【請求項6】 封入に用いる1気圧25℃で液体の油脂
成分及び/又は油脂組成物がシリコーン油、脂肪酸トリ
グリセライド、高級アルコールと脂肪酸のエステル及び
炭化水素から選択される1種乃至は2種以上であること
を特徴とする、請求項5に記載の角質細胞標本の作成方
法。
6. An oil and fat component and / or oil composition which is liquid at 1 atmosphere and 25 ° C. for encapsulation and is selected from one or more kinds selected from silicone oil, fatty acid triglyceride, esters of higher alcohols and fatty acids, and hydrocarbons. The method for producing a keratinocyte specimen according to claim 5, wherein
【請求項7】 角質細胞を含む試料が請求項1〜4何れ
か1項に記載の角質細胞の染色法によって染色されたも
のであることを特徴とする、請求項5又は6に記載の角
質細胞標本の作成方法。
7. The keratin according to claim 5, wherein the sample containing keratinocytes is stained by the method for staining keratinocytes according to any one of claims 1 to 4. How to make a cell specimen.
【請求項8】 角質細胞の面積測定、有核細胞の存在の
有無、有核細胞の出現頻度、角質細胞の配列の規則性、
角質細胞の形、及び角質細胞の剥離状況から選択される
1種乃至は2種以上の測定又は判別用であることを特徴
とする請求項5〜7何れか1項に記載の角質細胞標本の
作成方法。
8. The measurement of the area of keratinocytes, the presence or absence of nucleated cells, the frequency of appearance of nucleated cells, the regularity of the arrangement of keratinocytes,
The keratinocyte specimen according to any one of claims 5 to 7, which is for measuring or discriminating one or more kinds selected from the shape of keratinocytes and the detachment state of keratinocytes. How to make.
JP2002060346A 2001-10-29 2002-03-06 Keratinocyte staining method and keratinocyte preparation method Expired - Fee Related JP3618093B2 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
JP2002060346A JP3618093B2 (en) 2001-10-29 2002-03-06 Keratinocyte staining method and keratinocyte preparation method
KR10-2002-0017652A KR100458148B1 (en) 2001-10-29 2002-03-30 A skin analysis system
US10/123,440 US20030087333A1 (en) 2001-10-29 2002-04-15 Method for staining corneocites, method for preparing corneocites specimen and skin analysis system
TW091107588A TW531403B (en) 2001-10-29 2002-04-15 Method for staining corneocites, method for perparing corneocites specimen and skin analysis system
EP02252807A EP1306658A3 (en) 2001-10-29 2002-04-22 Method for preparing corneocyte specimens and staining corneocytes, and skin analysis system
EP07006149A EP1845359A3 (en) 2001-10-29 2002-04-22 Method for preparing corneocyte specimens and staining corneocytes, and skin analysis system
US10/847,761 US7425427B2 (en) 2001-10-29 2004-05-18 Method for staining corneocytes, method for preparing corneocytes specimen and skin analysis system
US10/848,233 US7421105B2 (en) 2001-10-29 2004-05-18 Method for staining corneocytes, method for preparing corneocytes specimen and skin analysis system
KR10-2004-0035831A KR100448303B1 (en) 2001-10-29 2004-05-20 A display data generating apparatus for skin analysis

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001331073 2001-10-29
JP2001-331073 2001-10-29
JP2002060346A JP3618093B2 (en) 2001-10-29 2002-03-06 Keratinocyte staining method and keratinocyte preparation method

Publications (2)

Publication Number Publication Date
JP2003202336A true JP2003202336A (en) 2003-07-18
JP3618093B2 JP3618093B2 (en) 2005-02-09

Family

ID=27666608

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002060346A Expired - Fee Related JP3618093B2 (en) 2001-10-29 2002-03-06 Keratinocyte staining method and keratinocyte preparation method

Country Status (1)

Country Link
JP (1) JP3618093B2 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006053117A (en) * 2004-07-12 2006-02-23 Pola Chem Ind Inc Liquid for dyeing corneocyte and method for dyeing corneocyte using it
WO2007029437A1 (en) * 2005-09-06 2007-03-15 Pola Chemical Industries Inc. Liquid dye for horny cells and method of dyeing horny cells by using the same
US8526689B2 (en) 2007-02-14 2013-09-03 Pola Chemical Industries Inc Method of supporting the differentiation of corneocytes
CN111951654A (en) * 2020-08-13 2020-11-17 大连鸿峰生物科技有限公司 Method and device for manufacturing skin specimen applied to marine mammal
CN113874704A (en) * 2019-05-23 2021-12-31 宝丽化学工业有限公司 Screening method of components influencing increase and decrease of stratum corneum intercellular adhesion protein
JP7396640B2 (en) 2019-11-05 2023-12-12 日本メナード化粧品株式会社 Staining method to determine the maturity of corneocytes

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006053117A (en) * 2004-07-12 2006-02-23 Pola Chem Ind Inc Liquid for dyeing corneocyte and method for dyeing corneocyte using it
WO2007029437A1 (en) * 2005-09-06 2007-03-15 Pola Chemical Industries Inc. Liquid dye for horny cells and method of dyeing horny cells by using the same
JPWO2007029437A1 (en) * 2005-09-06 2009-03-12 ポーラ化成工業株式会社 Staining solution for stratum corneum cells and method for staining stratum corneum cells using the same
US8526689B2 (en) 2007-02-14 2013-09-03 Pola Chemical Industries Inc Method of supporting the differentiation of corneocytes
CN113874704A (en) * 2019-05-23 2021-12-31 宝丽化学工业有限公司 Screening method of components influencing increase and decrease of stratum corneum intercellular adhesion protein
JP7396640B2 (en) 2019-11-05 2023-12-12 日本メナード化粧品株式会社 Staining method to determine the maturity of corneocytes
CN111951654A (en) * 2020-08-13 2020-11-17 大连鸿峰生物科技有限公司 Method and device for manufacturing skin specimen applied to marine mammal

Also Published As

Publication number Publication date
JP3618093B2 (en) 2005-02-09

Similar Documents

Publication Publication Date Title
Chamberlain Methods in plant histology
Goldschmidt et al. Exfoliative cytology of human horny layer: Methods of cell removal and microscopic techniques
US5109429A (en) Apparatus and method for analyses of biological specimens
Fisher Protein staining of ribboned epon sections for light microscopy
Crumpton A simple and reliable method for making permanent mounts of phytoplankton for light and fluorescence microscopy 1
WO1987002803A1 (en) An apparatus and method for analyses of biological specimens
JPH027427B2 (en)
KR100448303B1 (en) A display data generating apparatus for skin analysis
O'brien et al. Coagulant and non-coagulant fixation of plant cells
Maco et al. Correlative in vivo 2-photon imaging and focused ion beam scanning electron microscopy: 3D analysis of neuronal ultrastructure
JP2003202336A (en) Method for dyeing corneocyte and method for preparing corneocyte specimen
Yeung et al. Glycol methacrylate: The art of embedding and serial sectioning
Noyce et al. A practical method for staging grapevine inflorescence primordia in season 1, with improved description of stages
Roozemond Ultramicrochemical determination of nucleic acids in individual cells using the Zeiss UMSP-I microspectrophotometer. Application to isolated rat hepatocytes of different ploidy classes
US20060199243A1 (en) Cytological stain composition and methods of use
Dickinson et al. The identification of sporopollenin in sections of resin-embedded tissues by controlled acetolysis
US3796594A (en) Stain coated slides for differentially staining blood
JP3709382B2 (en) How to differentiate corneocytes
Derrick Infrared microspectroscopy in the analysis of cultural artifacts
WO2007029437A1 (en) Liquid dye for horny cells and method of dyeing horny cells by using the same
Da Costa et al. Immunolocalization of AGPs and pectins in Quercus suber gametophytic structures
CN102589956B (en) Method for identifying cordyceps sinensis through microscopic staining
JP2702211B2 (en) Hematoxylin staining solution
JP2000125854A (en) Dyeing of skin keratinocyte
Kwiatkowska et al. Sequential replicas for in vivo imaging of growing organ surfaces

Legal Events

Date Code Title Description
A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20040729

A131 Notification of reasons for refusal

Effective date: 20040817

Free format text: JAPANESE INTERMEDIATE CODE: A131

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040922

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Effective date: 20041102

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20041108

R150 Certificate of patent (=grant) or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees